Patent · US Expired

Material for use in the treatment of spontaneous abortions

US4558035A · kind A · utility

13Cited by
0References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 28, 1984
Grant dateDec 10, 1985
Priority date
Expiry dateFeb 28, 2004

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/851
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a material for use in preventing recurrent spontaneous abortions in women, comprising material selected from isolated syncytiotrophoblast microvillous plasma membrane and protein- and glycoprotein-containing fractions derived therefrom. The invention also relates to a method for preventing recurrent spontaneous abortions in women, the method comprising administering to a woman a material comprising material selected from isolated syncytiotrophoblast microvillous plasma membrane and protein- and glycoprotein-containing fractions derived therefrom.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.